share_log

12 Health Care Stocks Moving In Thursday's Intraday Session

Benzinga ·  Mar 15 01:31

Gainers

  • Psyence Biomedical (NASDAQ:PBM) shares rose 52.9% to $1.59 during Thursday's regular session. The company's market cap stands at $21.2 million.
  • Aptorum Gr (NASDAQ:APM) stock moved upwards by 43.65% to $6.22. The market value of their outstanding shares is at $32.2 million.
  • Mira Pharmaceuticals (NASDAQ:MIRA) stock moved upwards by 17.27% to $1.29. The company's market cap stands at $19.0 million.
  • TC BioPharm (Holdings) (NASDAQ:TCBP) shares moved upwards by 11.76% to $1.9. The company's market cap stands at $4.6 million.
  • Autonomix Medical (NASDAQ:AMIX) shares increased by 11.66% to $3.35. The market value of their outstanding shares is at $63.0 million.
  • Clearside Biomedical (NASDAQ:CLSD) stock moved upwards by 11.65% to $1.82. The market value of their outstanding shares is at $135.9 million. As per the news, the Q4 earnings report came out 2 days ago.

Losers

  • Better Therapeutics (NASDAQ:BTTX) stock fell 82.4% to $0.04 during Thursday's regular session. The market value of their outstanding shares is at $1.9 million.
  • Spruce Biosciences (NASDAQ:SPRB) stock fell 79.57% to $1.06. The market value of their outstanding shares is at $43.1 million. As per the news, the Q4 earnings report came out yesterday.
  • Immuneering (NASDAQ:IMRX) stock fell 48.73% to $3.02. The market value of their outstanding shares is at $88.2 million.
  • Sonida Senior Living (NYSE:SNDA) shares fell 26.43% to $19.0. The market value of their outstanding shares is at $219.1 million.
  • iSpecimen (NASDAQ:ISPC) shares fell 22.57% to $0.36. The market value of their outstanding shares is at $3.2 million. The company's, Q4 earnings came out yesterday.
  • TRACON Pharma (NASDAQ:TCON) shares decreased by 22.48% to $0.49. The company's market cap stands at $22.2 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment